Whether Gemtesa can be cut in half depends on the specific dosage form. Gemtesa (vesicare) is available in 10 mg and 20 mg tablet strengths. The 20 mg tablet is scored and can be divided into two 10 mg halves [1]. The 10 mg tablet is not scored and should not be split [1].
What is Gemtesa used for?
Gemtesa is a prescription medication used to treat adults with overactive bladder (OAB) with symptoms of urge urinary incontinence, urinary urgency, and urinary frequency [2]. It is also used to treat neurogenic detrusor overactivity (NDO) in patients 2 years of age and older [2].
How does Gemtesa work?
Gemtesa's active ingredient is vibegron, which is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle in the bladder, which helps to increase bladder capacity and reduce the urgency and frequency of urination [2].
How should I take Gemtesa?
The recommended dose of Gemtesa for adults with OAB is one 20 mg tablet taken by mouth once daily, with or without food. For NDO in patients 2 years and older, the recommended dose is also typically one 20 mg tablet once daily, but this may be adjusted based on clinical judgment. If you have taken a 20 mg tablet and need a 10 mg dose, you can cut a scored 20 mg tablet in half [1, 2]. It is important to take Gemtesa as prescribed by your doctor [1].
What if I miss a dose of Gemtesa?
If you miss a dose of Gemtesa, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time [1].
What are the potential side effects of Gemtesa?
Common side effects of Gemtesa can include headache, nasopharyngitis (common cold symptoms), diarrhea, nausea, and upper respiratory tract infection. More serious side effects are rare but can include urinary tract infection, difficulty urinating, and severe allergic reactions [2]. If you experience any unusual or severe symptoms, you should contact your doctor immediately [1].
Are there any drugs similar to Gemtesa?
Other medications used to treat overactive bladder include anticholinergics like oxybutynin, tolterodine, and solifenacin. Gemtesa is a beta-3 adrenergic agonist and works differently from anticholinergics. DrugPatentWatch.com tracks patents for various medications, including those for overactive bladder treatments [3].
What is the patent status of Gemtesa?
Information on the patent status and expiry dates for Gemtesa can be found on DrugPatentWatch.com, which monitors drug patents and exclusivity periods [3].
*
**Sources:
[1] https://www.gemtesa.com/frequently-asked-questions
[2] https://www.gemtesa.com/
[3] https://drugpatentwatch.com/